Skip to content

Reduction of Venous Emboli Load After Breathing Normobaric Oxygen Compared to Air

Mängden kvävgasbubblor i Blodet Efter Dykning Vid Syrgasandning jämfört Med Luftandning

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02468752
Enrollment
48
Registered
2015-06-11
Start date
2015-05-31
Completion date
2019-04-30
Last updated
2022-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Nervous Injury, Decompression Sickness, Diving Medicine, Endothelial Dysfunction, Hyperbaric, Inflammation

Brief summary

Primary objective: \- Assessment of venous gas emboli load post diving when breathing normobaric oxygen compared to air. Secondary objective: * Assessment of fluid markers of central nervous system injury in blood post diving * Assessment of fluid markers of inflammation and endothelial dysfunction in blood post diving Tertiary objective: \- Assessment of DCS frequency

Detailed description

This is a prospective, double blinded, randomized, cross-over study in Sweden. The study was performed in two different sets, each containing standardized dives in a wet hyperbaric chamber. The dives included movement on depth. In each study set 16-32 professional divers performed no-decompression dives to a depth of 42 metres of seawater (msw). The gas used during the dives was compressed air. After surfacing the divers breathed either normobaric oxygen or normobaric air on a demand mask. Timing of oxygen/air-breathing differed between study sets. The content of breathing gas was unknown to both divers and examining personnel. Immediately post dive the divers were assessed using either transthoracic doppler ultrasound (TTD) or transthoracic 2-D ultrasound (TTE) to determine VGE load, time to VGE detection and VGE duration. Signs of DCS were actively sought. TTD measurements were done every five minutes during the first 30 minutes, thereafter every 15 minutes during 90 minutes. TTE was performed every 30 minutes, using an apical 4-chamber view. Blood samples were obtained pre-dive, 30-45 minutes post-dive and 120 minutes post-dive. Set 1: 16 divers, divided into two equal groups (A and B). Dive to 42 msw during 10 min with a safety stop at five msw during three min. Immediately post dive breathing of oxygen (group A) or air (group B) during 30 min. VGE load, time to VGE detection and VGE duration is recorded. Blood samples were obtained pre-dive and 30 and 120 minutes post-dive. After 48 hours, the dives were repeated with switched gases between the groups. Set 2: 32 divers, divided into two equal groups (A and B). Dive to 42 msw during 10 min with a safety stop at five msw during three min. Fifteen minutes post dive breathing of oxygen (group A) or air (group B) during 30 min. VGE load, time to VGE detection and VGE duration is recorded. Blood samples were obtained pre-dive and 45 and 120 minutes post-dive, from the first 16 divers. After 48 hours, the dives were repeated with switched gases between the groups. Two further planned sets with repeated diving and shorter duration of oxygen/air-breathing were never carried through. AE including SAE will be recorded during the study. DCS may be considered either an AE or SAE depending on severity. Ongoing AE and SAE will be followed up.

Interventions

DRUGOxygen
OTHERAir

Sponsors

Swedish Armed Forces Diving and Naval Medicine Centre
CollaboratorOTHER
KTH Royal Institute of Technology
CollaboratorOTHER
Sahlgrenska University Hospital
CollaboratorOTHER
Göteborg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Professional diver * Fit to dive according to Swedish Navy standards

Exclusion criteria

* NONE

Design outcomes

Primary

MeasureTime frameDescription
Venous gas emboli120 minutesKisman-Masurel grading

Secondary

MeasureTime frameDescription
Inflammatory activity and endothelial dysfunction120 minutes/ 48 hoursE.g. VCAM-1, ICAM-1
Decompression sickness24 hoursClinical diagnosis
Markers of central nervous system injury120 minutes/ 48 hoursE.g. GFAP, Tau, NfL, UCHL-1

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026